Search Results - "De la Torre Hernandez, José M"

Acute Coronary Syndromes, Gastrointestinal Protection, and Recommendations Regarding Concomitant Administration of Proton-Pump Inhibitors ( Omeprazol / Esomeprazole ) and Clopidogrel by Lozano, Iñigo, MD, PhD, Sanchez-Insa, Esther, MD, de Leiras, Sergio Rodríguez, MD, PhD, Carrillo, Pilar, MD, PhD, Ruiz-Quevedo, Valeriano, MD, Pinar, Eduardo, MD, PhD, Gopar-Gopar, Silvia, MDr, Bayon, Jeremías, MD, Mañas, Pilar, MD, Lasa, Garikoitz, MD, CruzGonzalez, Ignacio, MD, PhD, Hernandez, Felipe, MD, PhD, Fernandez-Portales, Javier, MD, PhD, Fernandez-Fernandez, Javier, MD, Pérez-Serradilla, Ana, MD, de la Torre Hernandez, José M., MD, PhD, Gomez-Jaume, Alfredo, MD, PhD

“…The Food and Drug Administration and the European Medicines Agency sent a warning in 2010 discouraging the concomitant use of clopidogrel with omeprazole or…”
Get full text

Mitral Regurgitation After Transcatheter Aortic Valve Replacement: Prognosis, Imaging Predictors, and Potential Management by Cortés, Carlos, Amat-Santos, Ignacio J, Nombela-Franco, Luis, Muñoz-Garcia, Antonio J, Gutiérrez-Ibanes, Enrique, De La Torre Hernandez, José M, Córdoba-Soriano, Juan G, Jimenez-Quevedo, Pilar, Hernández-García, José M, Gonzalez-Mansilla, Ana, Ruano, Javier, Jimenez-Mazuecos, Jesús, Castrodeza, Javier, Tobar, Javier, Islas, Fabian, Revilla, Ana, Puri, Rishi, Puerto, Ana, Gómez, Itziar, Rodés-Cabau, Josep, San Román, José A

“…This study sought to analyze the clinical impact of the degree and improvement of mitral regurgitation in TAVR recipients, validate the main imaging…”
Get full text

Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI by Valgimigli, Marco, Cao, Davide, Angiolillo, Dominick J., Bangalore, Sripal, Bhatt, Deepak L., Ge, Junbo, Hermiller, James, Makkar, Raj R., Neumann, Franz-Josef, Saito, Shigeru, Picon, Hector, Toelg, Ralph, Maksoud, Aziz, Chehab, Bassem M., Choi, James W., Campo, Gianluca, De la Torre Hernandez, Jose M., Kunadian, Vijay, Sardella, Gennaro, Thiele, Holger, Varenne, Olivier, Vranckx, Pascal, Windecker, Stephan, Zhou, Yujie, Krucoff, Mitchell W., Ruster, Karine, Zheng, Yan, Mehran, Roxana

“…The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) among patients at high bleeding risk (HBR) is unknown…”
Get full text

Outcomes Prediction in Complex High-Risk Indicated Percutaneous Coronary Interventions in the Older Patients by Marschall, Alexander, Martí Sánchez, David, Ferreiro, José Luis, Lopez Palop, Ramon, Ojeda, Soledad, Avanzas, Pablo, Jimenez Mazuecos, Jesus M., Carrillo Sáez, Pilar, Gutierrez-Barrios, Alejandro, de la Torre Hernandez, Jose M.

“…Complex high-risk indicated percutaneous coronary intervention (CHIP-PCI) is a poorly defined concept, which has not been validated in an older population…”
Get full text

One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease by Mankerious, Nader, Toelg, Ralph, Vogel, Birgit, Sartori, Samantha, Angiolillo, Dominick J., Vranckx, Pascal, Feng, Yihan, de la Torre Hernandez, Jose M., Krucoff, Mitchell W., Bhatt, Deepak L., Spirito, Alessandro, Cao, Davide, Chehab, Bassem M., Kunadian, Vijay, Maksoud, Aziz, Picon, Hector, Sardella, Gennaro, Thiele, Holger, Varenne, Olivier, Windecker, Stephan, Richardt, Gert, Valgimigli, Marco, Mehran, Roxana

“…•High bleeding risk patients receiving cobalt-chromium everolimus-eluting stents were enrolled.•Chronic kidney disease (CKD) was highly prevalent.•CKD patients…”
Get full text

A Mechanical Approach for Smooth Surface Fitting to Delineate Vessel Walls in Optical Coherence Tomography Images by Olender, Max L., Athanasiou, Lambros S., de la Torre Hernandez, Jose M., Ben-Assa, Eyal, Nezami, Farhad Rikhtegar, Edelman, Elazer R.

“…Automated analysis of vascular imaging techniques is limited by the inability to precisely determine arterial borders. Intravascular optical coherence…”
Get full text

One-year cardiovascular outcomes after coronavirus disease 2019: The cardiovascular COVID-19 registry by Ortega-Paz, Luis, Arévalos, Victor, Fernández-Rodríguez, Diego, Jiménez-Díaz, Víctor, Bañeras, Jordi, Campo, Gianluca, Rodríguez-Santamarta, Miguel, Díaz, José Francisco, Scardino, Claudia, Gómez-Álvarez, Zaira, Pernigotti, Alberto, Alfonso, Fernando, Amat-Santos, Ignacio J, Silvestro, Antonio, Rampa, Lorenzo, de la Torre Hernández, José M, Bastidas, Gabriela, Gómez-Lara, Josep, Bikdeli, Behnood, García-García, Hector M, Angiolillo, Dominick J, Rodés-Cabau, Josep, Sabaté, Manel, Brugaletta, Salvatore

“…The long-term cardiovascular (CV) outcomes of COVID-19 have not been fully explored. This was an international, multicenter, retrospective cohort study…”
Get full text

Individual Patient Data Meta-analysis of Drug-eluting Versus Bare-metal Stents for Percutaneous Coronary Intervention in Chronic Versus Acute Coronary Syndromes by Piccolo, Raffaele, Bonaa, Kaare H., Efthimiou, Orestis, Varenne, Olivier, Baldo, Andrea, Urban, Philip, Kaiser, Christoph, de Belder, Adam, Lemos, Pedro A., Wilsgaard, Tom, Reifart, Jörg, Ribeiro, Expedito E., Serruys, Patrick WJC, Byrne, Robert A., de la Torre Hernandez, Jose M., Esposito, Giovanni, Wijns, William, Jüni, Peter, Windecker, Stephan, Valgimigli, Marco

“…New-generation drug-eluting stents (DES) strongly reduce restenosis and repeat revascularization compared with bare-metal stents (BMS) for percutaneous…”
Get full text

Mechanical Complications in Elderly Patients With Myocardial Infarction: Becoming Fewer But Just as Fatal by de la Torre Hernández, José M.

“…[Display omitted]…”
Get full text

Antithrombotic treatment during coronary angioplasty after failed thrombolysis: strategies and prognostic implications. Results of the RESPIRE registry by De la Torre Hernández, José M, Sadaba Sagredo, Mario, Telleria Arrieta, Miren, Gimeno de Carlos, Federico, Sanchez Lacuesta, Elena, Bullones Ramírez, Juan A, Pineda Rocamora, Javier, Martin Yuste, Victoria, Garcia Camarero, Tamara, Larman, Mariano, Rumoroso, Jose R

“…Thrombolysis is still used when primary angioplasty is delayed for a long time, but 25%-30% of patients require rescue angioplasty (RA). There are no…”
Get full text

Intraprocedural delayed reassessment of paravalvular regurgitation in TAVR significantly reduces the use of postdilatation by De la Torre Hernandez, Jose M., Veiga Fernandez, Gabriela, Barrera, Sergio, Sainz Laso, Fermin, Lee, Dae‐Hyun, Ruisanchez Villar, Cristina, Lerena, Piedad, Garcia Camarero, Tamara, Cuesta Cosgaya, Jose M., Gil Ongay, Aritz, Zueco, Javier

“…Objectives We sought to investigate the effect of a 15‐min delayed intraprocedural reassessment of paravalvular aortic regurgitation (PVR) after an immediate…”
Get full text

A Prospective Randomized Trial of Everolimus-Eluting Stents Versus Bare-Metal Stents in Octogenarians by de Belder, Adam, MD, de la Torre Hernandez, Jose M., MD, PhD, Lopez-Palop, Ramon, PhD, O'Kane, Peter, MD, Hernandez Hernandez, Felipe, MD, Strange, Julian, MD, Gimeno, Federico, PhD, Cotton, James, MD, Diaz Fernandez, Jose F., MD, Carrillo Saez, Pilar, PhD, Thomas, Martyn, MD, Pinar, Eduardo, PhD, Curzen, Nick, PhD, Baz, Jose A., MD, Cooter, Nina, RCN, Lozano, Inigo, PhD, Skipper, Nicola, RCN, Robinson, Derek, PhD, Hildick-Smith, David, MD

“…Objectives The aim of this study was to determine whether drug-eluting stents (DES) are superior to bare-metal stents (BMS) in octogenarian patients with…”
Get full text

Early healing assessment with optical coherence tomography of everolimus-eluting stents with bioabsorbable polymer (synergy™) at 3 and 6 months after implantation by de la Torre Hernández, Jose M., Tejedor, Paula, Camarero, Tamara Garcia, Duran, Juan M., Lee, Dae-Hyun, Monedero, Jairo, Laso, Fermin Sainz, Calderón, Marcos Alvarez, Veiga, Gabriela, Zueco, Javier

“…Objectives In this study we sought to evaluate coverage and apposition of Synergy™ stent at 3 and 6 months after implantation. Background The Pt‐Cr…”
Get full text

A brief look into Bayesian statistics in cardiology data analysis by Armero, Carmen, Rodríguez, and, Patricia, Torre Hernández, José M. de la

“…ABSTRACT Bayesian statistics assesses probabilistically all sources of uncertainty involved in a statistical study and uses Bayes' theorem to sequentially…”
Get full text

Marking a milestone. REC: Interventional Cardiology assigned its first impact factor by Torre-Hernández, José M. de la, Alfonso, Fernando, Moren, Raúl, Ojeda, Soledad, Prado, and, Armando Pérez de, Romaguera, Rafael

“…At the time of drafting this Editor's page, we were thrilled to learn that REC: Interventional Cardiology has received its very first impact factor (IF) of 1.4…”
Get full text

Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions by Räber, Lorenz, Mintz, Gary S, Koskinas, Konstantinos C, Johnson, Thomas W, Holm, Niels R, Onuma, Yoshinubo, Radu, Maria D, Joner, Michael, Yu, Bo, Jia, Haibo, Meneveau, Nicolas, de la Torre Hernandez, Jose M, Escaned, Javier, Hill, Jonathan, Prati, Francesco, Colombo, Antonio, di Mario, Carlo, Regar, Evelyn, Capodanno, Davide, Wijns, William, Byrne, Robert A, Guagliumi, Giulio

“…Abstract This Consensus Document is the first of two reports summarizing the views of an expert panel organized by the European Association of Percutaneous…”
Get full text

Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular Collaboratory by Spitzer, Ernest, Torre Hernández, José M. de la, Jóna Guðmundsdóttir, Ingibjörg, McFadden, Eugene, Held, Claes, Hanet, Claude, Boersma, Eric, B. Ren, Claire, Delgado, Victoria, Erlinge, David, de Prado, Armando Pérez, Bax, and, Jeroen J., G.P. Tijssen, Jan

“…On May 26, 2021, the European Medical Device Regulation (EU-MDR) entered into effect resulting in a major shift in the requirements for assessment of medical…”
Get full text

Implementation of Institutional Protocols for Patients With Acute Coronary Syndrome: Nonclinical Factors Also Matter by Lozano, Iñigo, Sanchez Perez, Andres, Sanchez-Insa, Esther, Mechan, Juan Carlos Rama, Gopar, Silvia, Ruiz-Quevedo, Valeriano, Fernandez Fernandez, Javier, Gomez-Jaume, Alfredo, Bayon, Jeremias, Lasa, Garikoitz, Fernandez-Portales, Javier, Hernandez, Jose M. de la Torre, Mañas, Pilar, Pinar, Eduardo, Lopez-Palop, Ramon, Albarran, Agustin, de Leiras, Sergio Rodriguez

Get full text

New TAVI technique for difficult valve crossing by Torre-Hernández, José M. de la, Veiga Fernández, Gabriela, Barrera, Sergio, Sainz Laso, Fermín, Lee, Dae-Hyun, García Camarero, and Tamara

“…Figura 1 This is the case of an 83-year-old man with symptomatic, severe aortic valve stenosis referred for transcatheter aortic valve implantation (TAVI). The…”
Get full text

REC: Interventional Cardiology: on the right track by Torre-Hernández, José M. de la, Alfonso, Fernando, Moreno, Raúl, Ojeda, Soledad, Prado, and, Armando Pérez de, Romaguera, Rafael

“…At the time of writing, 4 years have gone by since REC: Interventional Cardiology made its publishing appearance for the first time. Overall, these have been…”
Get full text